Chemicals division

Chemistry Division Manager: Joulia LARIONOVA

Administrative and management assistant: Eva BALENTOVA

Head of the Human Resources Commission (CRH): Michael SMIETANA

HR administrative manager and Pôle chimie support: Virginie GARCIA-ROBERT

Pole Office

The role of the board is to prepare the cluster's board meetings and monitor the progress of its activities. It is also a forum for exchanging and sharing strategic information concerning the operation of the research cluster.

The operational team is responsible for setting up and carrying out the research cluster's missions, and for providing scientific leadership within the community on specific themes.

Pôle de Research Chimie white paper

By-laws of the Pôle de Research Chimie

Internal regulations of the Pôle de Research Chimie

Strategic Orientation Committee (COS)

The Strategic Orientation Committee provides a link between Pôle de Research and its institutional partners. It participates in defining the Pôle de Research 's major scientific strategic orientations, and gives its opinion on the action plan proposed by the Director of the Pôle de Research.

Pole Council

The Conseil de Pôle issues advisory opinions on the direction and implementation of the Pôle's actions and strategy.

The Pôle Board is made up of 22 members with voting rights and invited members with consultative rights.

Human Resources Commission (CRH)

The Human Resources Commission deals with issues specific to the staff of the University of Montpellier. Each Human Resources Commission issues an advisory opinion, in compliance with the statutory provisions specific to the Professors and Researchers corps.

The chemistry cluster brings together all the chemical science research players at the Montpellier and Marcoule sites, supported by :

• 4 Joint Research Units (Unités Mixtes de Recherche) attached on a principal basis
  • IBMM - Max Mousseron Biomolecules Institute
  • ICGM - Charles Gerhardt Institute Montpellier
  • ICSM - Marcoule Institute of Separative Chemistry
  • IEM - European Membrane Institute
• 3 research structures attached to the Cluster on a secondary basis
  • ChimEco - Laboratory for Bio-inspired Chemistry and Ecological Innovations
  • CBS - Center for Structural Biology
  • L2C - Charles Coulombe Laboratory Montpellier
• 1 research and support unit (UAR)
  • UAR 2041 PAC Chimie Balard 
• 3 technology platforms
  • ChemLab
  • Glass workshop
  • Chemicals reserve

The Chemistry cluster works in collaboration with the Institut Carnot Chimie Balard CIRIMAT, which groups together partnership and development activities, and the Ecole Doctorale Sciences Chimiques Balard ED459, which welcomes an average of 265 doctoral students a year.

Trustee institutions

• UM - Montpellier Universities
• CNRS - French National Center for Scientific Research
• ENSCM - Montpellier National School of Chemistry
• CEA - French Atomic Energy and Alternative Energies Commission

Pricing

• Glass workshop
• PAC Chimie Balard
• RPC

The Chemistry Research Centre is responsible for :

• Establish a scientific leadership within the community on axes or thematic fields and identify a scientific prospective ;
• Promote and coordinate responses to calls for cross-sectoral, regional, national or international projects ;
• Participate in the deployment of the University of Montpellier's international strategy and visibility ;
• Proposing concerted actions to promote the link between Training and Research
• Participate in job and skills forecasting ;
• To ensure that the Human Resources Commission operates in such a way as to produce opinions on issues specific to human resources in research at the University of Montpellier.

The cluster's cross-disciplinary research themes are organized around the 5 priority areas of the 4 institutes (IBMM, ICGM, ICSM, IEM) and UAR 2041 :

1. ENERGY :
   • Synthesis, separation, storage and detection of gases (hydrogen, CO2, etc.)
   • Lithium and sodium batteries, supercapacitors
   • Biofuels, synthetic fuels, catalysts
   • Low-carbon energy, sustainable nuclear power
2. GREEN AND SUSTAINABLE CHEMISTRY
   • Substitution of hazardous compounds and metals
   • Alternative solvents, bio-based composite materials
   • Biomass valorization
3. HEALTH
   • Biomolecules, formulation of active ingredients
   • Functional excipients, controlled release systems
   • Tissue engineering, medical devices
4. EXTRACTION-SEPARATION
   • Water and liquid effluent treatment
   • Gas separation
   • Extraction of valuable species, recycling
5. HIGH-PERFORMANCE MATERIALS
   • Thin films and functional coatings
   • Nanocomposites, nanotubes and 2D materials
   • Innovative ceramics and polymers, additive manufacturing

Training and Research Units (UFR), schools and institutes of the University of Montpellier linked to the Chemistry Research Cluster.

• Montpellier chemistry engineering school: École Nationale de Chimie à Montpellier - ENSCM
• Faculty of Pharmacy (Pharmaceutical and Biological Sciences UFR)
• Faculty of Science
• Faculty of Medicine
• IUT Montpellier - Sète
• IUT Nîmes
• Polytech Montpellier

6 ANR joint laboratories

4 Joint Research Units (IBMM, ICGM, ICSM, IEM)

328 teachers-researchers & researchers

172 ITA

500 permanent staff

850 permanent and non-permanent staff

1 Research Support Unit (UAR 2041 PAC Chimie Balard)

3 Platforms (ChemLab, Glass Workshop, Chemical Product Reserve (CPR))

50 items /+ of equipment

1 Institut Carnot Chimie Balard Cirimat, ISO 9001:2015 "100 industrial partners under direct contract/year".

1 doctoral school (Sciences Chimiques Balard) "265 doctoral students

32M€ Consolidated research budget/year

Innovation & Valorization

14 Startups since 2009

22 Active licenses

>212 Patents filed since 2014

2 Marketed drugs (^MacrilenTM, Sebivo) The first compound is a pseudo-peptide used to diagnose growth hormone deficiency in adults, the fruit of work carried out under the direction of Jean Martinez. It has been marketed by Æterna Zentaris in North America since 2018, and in Europe since 2019. The second compound is a non-natural antiviral nucleoside used against hepatitis B, developed by Dr. Gilles Gosselin and Prof. Jean-Louis Imbach, and marketed by Merck.